Do the frequencies of adverse events increase, decrease, or stay the same with long-term use of statins?

Current atherosclerosis reports

Volumn 15, Issue 2, 2013, Pages

  Huddy, Karlyn ^a   Dhesi, Pavittarpaul ^b   Thompson, Paul D ^b  

^a HARTFORD HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED DISORDER; DRUG TOXICITY; HEALTH; HUMAN; MORBIDITY; REVIEW;

CARDIOVASCULAR DISEASES; DRUG TOXICITY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MORBIDITY; WORLD HEALTH;

EID: 84879538387     PISSN: None     EISSN: 15346242     Source Type: None    
DOI: 10.1007/s11883-012-0301-9     Document Type: Review

References (0)